Literature DB >> 24818748

Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence.

Yingxi Xu1, Na Li2, Rong Xiang2, Peiqing Sun3.   

Abstract

Oncogene-induced senescence (OIS) is a tumor-suppressing response that must be disrupted for cancer to develop. Mechanistic insights into OIS have begun to emerge. Activation of the p53/p21(WAF1) and/or p16(INK4A) tumor-suppressor pathways is essential for OIS. Moreover, the DNA damage response, chromatin remodeling, and senescence-associated secretory phenotype (SASP) are important for the initiation and maintenance of OIS. This review discusses recent advances in elucidating the mechanisms of OIS, focusing on the roles of the p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/cellular homolog of murine thymoma virus AKT/mammalian target of rapamycin (mTOR) pathways. These studies indicate that OIS is mediated by an intricate signaling network. Further delineation of this network may lead to development of new cancer therapies targeting OIS.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AKT; oncogene-induced senescence; p38; phosphoinositide 3-kinase

Mesh:

Substances:

Year:  2014        PMID: 24818748      PMCID: PMC4358807          DOI: 10.1016/j.tibs.2014.04.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  72 in total

1.  PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.

Authors:  Naoto Yoshizuka; Maoyi Lai; Rong Liao; Ryan Cook; Changchun Xiao; Jiahuai Han; Peiqing Sun
Journal:  Mol Cancer Res       Date:  2012-06-04       Impact factor: 5.852

2.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

3.  Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.

Authors:  Jimin Shin; Jiwon Yang; Jang Choon Lee; Kwan-Hyuck Baek
Journal:  Cell Signal       Date:  2013-08-30       Impact factor: 4.315

4.  Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.

Authors:  C Bassi; J Ho; T Srikumar; R J O Dowling; C Gorrini; S J Miller; T W Mak; B G Neel; B Raught; V Stambolic
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

Review 5.  Controversial aspects of oncogene-induced senescence.

Authors:  Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

6.  A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis.

Authors:  Naoto Yoshizuka; Rebecca M Chen; Zeyu Xu; Rong Liao; Lixin Hong; Wen-Yuan Hu; Guoliang Yu; Jiahuai Han; Longchuan Chen; Peiqing Sun
Journal:  Mol Cell Biol       Date:  2011-11-28       Impact factor: 4.272

7.  Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Authors:  Liesbeth C W Vredeveld; Patricia A Possik; Marjon A Smit; Katrin Meissl; Chrysiis Michaloglou; Hugo M Horlings; Abderrahim Ajouaou; Pim C Kortman; David Dankort; Martin McMahon; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

8.  ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.

Authors:  Ryo Kodama; Masayoshi Kato; Shuichi Furuta; Shouta Ueno; Yugen Zhang; Kuniharu Matsuno; Chihiro Yabe-Nishimura; Eiji Tanaka; Tohru Kamata
Journal:  Genes Cells       Date:  2012-12-06       Impact factor: 1.891

9.  A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence.

Authors:  Hui Zheng; Alim Seit-Nebi; Xuemei Han; Aaron Aslanian; John Tat; Rong Liao; John R Yates; Peiqing Sun
Journal:  Mol Cell       Date:  2013-05-16       Impact factor: 17.970

10.  AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.

Authors:  M V Astle; K M Hannan; P Y Ng; R S Lee; A J George; A K Hsu; Y Haupt; R D Hannan; R B Pearson
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

View more
  96 in total

Review 1.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  Transcriptomic Analysis of Cellular Pathways in Healing Flexor Tendons of Plasminogen Activator Inhibitor 1 (PAI-1/Serpine1) Null Mice.

Authors:  Margaret A T Freeberg; Anas Easa; Jacquelyn A Lillis; Danielle S W Benoit; Andre J van Wijnen; Hani A Awad
Journal:  J Orthop Res       Date:  2019-09-01       Impact factor: 3.494

3.  Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production.

Authors:  Zoe E Gillespie; Kimberly MacKay; Michelle Sander; Brett Trost; Wojciech Dawicki; Aruna Wickramarathna; John Gordon; Mark Eramian; Ian R Kill; Joanna M Bridger; Anthony Kusalik; Jennifer A Mitchell; Christopher H Eskiw
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

4.  Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes Inflammation-induced Preterm Birth.

Authors:  Xiaofei Sun; Wenbo Deng; Yingju Li; Shuang Tang; Emma Leishman; Heather B Bradshaw; Sudhansu K Dey
Journal:  J Biol Chem       Date:  2016-02-21       Impact factor: 5.157

5.  Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.

Authors:  Juan Li; Xuefei Feng; Canyu Li; Jie Liu; Pingping Li; Ruiqi Wang; He Chen; Peijun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-02

6.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

7.  Unmasking Transcriptional Heterogeneity in Senescent Cells.

Authors:  Alejandra Hernandez-Segura; Tristan V de Jong; Simon Melov; Victor Guryev; Judith Campisi; Marco Demaria
Journal:  Curr Biol       Date:  2017-08-30       Impact factor: 10.834

8.  γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16INK4a pathway.

Authors:  Azalina Zainuddin; Kien-Hui Chua; Jen-Kit Tan; Faizul Jaafar; Suzana Makpol
Journal:  J Physiol Biochem       Date:  2016-10-14       Impact factor: 4.158

Review 9.  WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects.

Authors:  Koutaro Yokote; Sirisak Chanprasert; Lin Lee; Katharina Eirich; Minoru Takemoto; Aki Watanabe; Naoko Koizumi; Davor Lessel; Takayasu Mori; Fuki M Hisama; Paula D Ladd; Brad Angle; Hagit Baris; Kivanc Cefle; Sukru Palanduz; Sukru Ozturk; Antoinette Chateau; Kentaro Deguchi; T K M Easwar; Antonio Federico; Amy Fox; Theresa A Grebe; Beverly Hay; Sheela Nampoothiri; Karen Seiter; Elizabeth Streeten; Raul E Piña-Aguilar; Gemma Poke; Martin Poot; Renata Posmyk; George M Martin; Christian Kubisch; Detlev Schindler; Junko Oshima
Journal:  Hum Mutat       Date:  2016-10-07       Impact factor: 4.878

10.  Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Authors:  Emilija Manojlovic-Gacic; Milica Skender-Gazibara; Vera Popovic; Ivan Soldatovic; Novica Boricic; Savo Raicevic; Sandra Pekic; Mirjana Doknic; Dragana Miljic; Irina Alafuzoff; Fredrik Pontén; Olivera Casar-Borota
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.